Filter posts

Make Medical Research a National Priority

Biomedical and health research fuels private sector innovation and the development of new therapies and …

Who Cares About ALS?

1,100 days. That’s the average amount of time a person survives following a diagnosis of …

Act Now to Protect Public Health and Prepare for the Upcoming Flu Season

As many as 49,000 people die from the flu annually, depending on the season, and …

Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry

During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other …

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

As biopharmaceutical manufacturers consider the new reality of accountable care organizations (ACOs) and the impact …

BioGENEius – From Student Participant to Judge

It’s been two years since I participated as a student in BioGENEius. Last year I …

The Affordable Care Act is Here to Stay

The Patient Protection and Affordable Care Act (ACA) of 2010 includes provisions that could lead …

Debt, Taxes and Politics: Is There a Way Out?

BIO President and CEO Jim Greenwood kicked off a keynote discussion with Sen. Alan Simpson …

Spotlight on China

The 20th annual BIO International Convention is wrapping up in Chicago. Experts and leaders from …

The Rise of Specialty Pharmaceuticals

Fact: Specialty pharmaceuticals represented nearly 25 percent of all drug spending last year. By 2018, …